On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...